Association between PON1 5′-regulatory region polymorphisms, PON1 activity and ischemic stroke

Clinical Biochemistry

Volumn 42, Issue 9, 2009, Pages 857-863

  Kim, No Soo ^a   Kang, Byoung Kab ^a   Cha, Min Ho ^a   Oh, Se Mi ^a   Ko, Mi Mi ^a   Bang, Ok Sun ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Association; Haplotype; Ischemic stroke; Polymorphism; PON1; Risk factor

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROL GROUP; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ARYLDIALKYLPHOSPHATASE; BRAIN ISCHEMIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; STROKE;

EID: 67349165037     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.02.008     Document Type: Article

References (30)

1. Watson A.D., Berliner J.A., Hama S.Y., et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin Invest. 96 (1995) 2882-2891
2. Mackness M.I., Arrol S., and Durrington P.N. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett. 286 (1991) 152-154
3. Shih D.M., Gu L., Xia Y.R., et al. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394 (1998) 284-287
4. Ozer E.A., Pezzulo A., Shih D.M., et al. Human and murine paraoxonase 1 are host modulators of Pseudomonas aeruginosa quorum-sensing. FEMS Microbiol. Lett. 253 (2005) 29-37
5. Matsushita A., Iwase M., Kato Y., et al. Differential cardiovascular effects of endotoxin derived from Escherichia coli or Pseudomonas aeruginosa. Exp. Anim. 56 (2007) 339-348
6. Schmidt H., Schmidt R., Niederkorn K., et al. Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study. Stroke 29 (1998) 2043-2048
7. Voetsch B., Benke K.S., Damasceno B.P., et al. Paraoxonase 192 Gln → Arg polymorphism: an independent risk factor for nonfatal arterial ischemic stroke among young adults. Stroke 33 (2002) 1459-1464
8. Bhattacharyya T., Nicholls S.J., Topol E.J., et al. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA 299 (2008) 1265-1276
9. Costa L.G., Cole T.B., Jarvik G.P., et al. Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annu. Rev. Med. 54 (2003) 371-392
10. Huang Q., Liu Y.H., Yang Q.D., et al. Human serum paraoxonase gene polymorphisms, Q192R and L55M, are not associated with the risk of cerebral infarction in Chinese Han population. Neurol. Res. 28 (2006) 549-554
11. Pasdar A., Ross-Adams H., Cumming A., et al. Paraoxonase gene polymorphisms and haplotype analysis in a stroke population. BMC Med. Genet. 7 (2006) 28
12. Brophy V.H., Hastings M.D., Clendenning J.B., et al. Polymorphisms in the human paraoxonase (PON1) promoter. Pharmacogenetics 11 (2001) 77-84
13. Voetsch B., Benke K.S., Panhuysen C.I., et al. The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults. Arch. Neurol. 61 (2004) 351-356
14. James R.W., Leviev I., Ruiz J., et al. Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients. Diabetes 49 (2000) 1390-1393
15. Erlich P.M., Lunetta K.L., Cupples L.A., et al. Polymorphisms in the PON gene cluster are associated with Alzheimer disease. Hum. Mol. Genet. 15 (2006) 77-85
16. Cellini E., Tedde A., Bagnoli S., et al. Association analysis of the paraoxonase-1 gene with Alzheimer's disease. Neurosci. Lett. 408 (2006) 199-202
17. Hofer S.E., Bennetts B., Chan A.K., et al. Association between PON 1 polymorphisms, PON activity and diabetes complications. J. Diabetes Complications 20 (2006) 322-328
18. Hong S.H., Song J., Min W.K., et al. Genetic variations of the paraoxonase gene in patients with coronary artery disease. Clin. Biochem. 34 (2001) 475-481
19. Shin B.S., Oh S.Y., Kim Y.S., et al. The paraoxonase gene polymorphism in stroke patients and lipid profile. Acta Neurol. Scand. 117 (2008) 237-243
20. Kim N.S., Kang K., Cha M.H., et al. Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans. Biochem. Biophys. Res. Commun. 364 (2007) 157-162
21. Beltowski J., Wojcicka G., and Marciniak A. Species- and substrate-specific stimulation of human plasma paraoxonase 1 (PON1) activity by high chloride concentration. Acta Biochim. Pol. 49 (2002) 927-936
22. Hong S.H., Park H.M., Ahn J.Y., et al. ACE I/D polymorphism in Korean patients with ischemic stroke and silent brain infarction. Acta Neurol. Scand. 117 (2008) 244-249
23. Kim Y., Kim J.H., Nam Y.J., et al. Klotho is a genetic risk factor for ischemic stroke caused by cardioembolism in Korean females. Neurosci. Lett. 407 (2006) 189-194
24. Seo J.C., Han S.W., Yin C.S., et al. Evaluation of a Apo-1/Fas promoter polymorphism in Korean stroke patients. Exp. Mol. Med. 34 (2002) 294-298
25. Lee C., and Kong M. An interactive association of common sequence variants in the neuropeptide Y gene with susceptibility to ischemic stroke. Stroke 38 (2007) 2663-2669
26. Rozenberg O., Shih D.M., and Aviram M. Human serum paraoxonase 1 decreases macrophage cholesterol biosynthesis: possible role for its phospholipase-A2-like activity and lysophosphatidylcholine formation. Arterioscler Thromb. Vasc. Biol. 23 (2003) 461-467
27. Leviev I., and James R.W. Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arterioscler Thromb. Vasc. Biol. 20 (2000) 516-521
28. Forte T.M., Oda M.N., Knoff L., et al. Targeted disruption of the murine lecithin:cholesterol acyltransferase gene is associated with reductions in plasma paraoxonase and platelet-activating factor acetylhydrolase activities but not in apolipoprotein J concentration. J. Lipid. Res. 40 (1999) 1276-1283
29. Jaouad L., de Guise C., Berrougui H., et al. Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1's free sulfhydryl groups. Atherosclerosis 185 (2006) 191-200
30. Balcerzyk A., Zak I., and Krauze J. Synergistic effects between Q192R polymorphism of paraoxonase 1 gene and some conventional risk factors in premature coronary artery disease. Arch. Med. Res. 38 (2007) 545-550